BlackRock’s Unicycive Therapeutics UNCY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-8,324
| Closed | -$47.9K | – | 5505 |
|
|
2025
Q1 | $47.9K | Buy |
8,324
+1,097
| +15% | +$6.31K | ﹤0.01% | 4880 |
|
|
2024
Q4 | $57.4K | Buy |
7,227
+45
| +0.6% | +$357 | ﹤0.01% | 4855 |
|
|
2024
Q3 | $29.3K | Buy |
7,182
+1,998
| +39% | +$8.15K | ﹤0.01% | 4843 |
|
|
2024
Q2 | $26K | Buy |
+5,184
| New | +$26K | ﹤0.01% | 4919 |
|
|
2022
Q2 | – | Sell |
-2,417
| Closed | -$31K | – | 5859 |
|
|
2022
Q1 | $31K | Buy |
2,417
+812
| +51% | +$10.4K | ﹤0.01% | 5415 |
|
|
2021
Q4 | $33K | Buy |
1,605
+461
| +40% | +$9.48K | ﹤0.01% | 5402 |
|
|
2021
Q3 | $33K | Buy |
+1,144
| New | +$33K | ﹤0.01% | 5278 |
|